US Stock MarketDetailed Quotes
MREO Mereo BioPharma
- 3.9560
- +0.0760+1.96%
Trading Jul 22 15:34 ET
604.48MMarket Cap-26373P/E (TTM)
4.0000High3.7600Low499.52KVolume3.8600Open3.8800Pre Close1.95MTurnover0.50%Turnover RatioLossP/E (Static)152.80MShares4.500052wk High14.13P/B394.70MFloat Cap1.070052wk Low--Dividend TTM99.77MShs Float8.4800Historical High--Div YieldTTM6.19%Amplitude0.3010Historical Low3.8960Avg Price1Lot Size
Mereo BioPharma Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 10M | 8.99M | 0 | 0 | 49.21M | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --10M | --8.99M | --0 | --0 | --49.21M | --0 | --0 | --0 | --0 |
| Cost of revenue | 0 | 324.61%2.57M | 3.44M | -347K | -104.74%-1.15M | 24.17M | 0 | 0 | -34.40%22.7M | 40.89%34.61M |
| Gross profit | 0 | 547.99%7.43M | 5.55M | 347K | -95.42%1.15M | 25.04M | 0 | 0 | 34.40%-22.7M | -34.61M |
| Operating expense | -16.30%9.42M | -35.81%34.56M | 10.75M | 11.26M | 1.02%53.84M | 4.10%53.3M | -1.18%51.2M | 340.03%51.81M | 10.08%11.78M | -7.92%10.7M |
| Selling and administrative expenses | -8.43%5.91M | -29.43%18.42M | --5.59M | --6.45M | 21.41%26.11M | -25.65%21.5M | 38.65%28.92M | 77.15%20.86M | 10.08%11.78M | -7.92%10.7M |
| -General and administrative expense | -8.43%5.91M | -29.43%18.42M | --5.59M | --6.45M | 21.41%26.11M | -25.65%21.5M | 38.65%28.92M | 77.15%20.86M | 10.08%11.78M | -7.92%10.7M |
| Research and development costs | -24.74%3.99M | -40.89%17.42M | --4.65M | --5.31M | -7.33%29.47M | 42.72%31.8M | -28.03%22.28M | --30.95M | ---- | ---- |
| Other operating expenses | 4.41%-477K | 25.93%-1.28M | ---- | ---499K | ---1.73M | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 13.64%-9.42M | 48.51%-27.14M | -5.2M | -10.91M | -86.50%-52.7M | 44.81%-28.26M | 1.18%-51.2M | -50.28%-51.81M | 23.90%-34.48M | -25.22%-45.3M |
| Net non-operating interest income expense | 162.15%307K | 77.51%-750K | -805.14K | -494K | 38.55%-3.34M | 37.18%-5.43M | -48.06%-8.64M | -112.32%-5.83M | -3,715.79%-2.75M | -61.05%76K |
| Non-operating interest income | 101.63%617K | 153.69%2.13M | --284.29K | --306K | 62,138.96%840K | -80.19%1.35K | -97.16%6.81K | -21.84%239.94K | -62.88%307K | 120.59%827K |
| Non-operating interest expense | -61.25%310K | -30.99%2.88M | --1.06M | --800K | -22.68%4.18M | -37.92%5.4M | 37.73%8.7M | 106.74%6.32M | 514.69%3.06M | 176.47%497K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | 153.33%28.34K | 77.97%-53.15K | ---241.25K | ---- | --254K |
| Other net income (expense) | 124.59%165K | -116.13%-2.11M | -587.78K | -671K | -75.25%13.1M | 131.68%52.9M | -4,570.69%-167M | 4,769.39%3.74M | 95.36%-80K | -176.15%-1.72M |
| Gain on sale of security | 124.81%165K | -117.50%-2.1M | ---697.21K | ---665K | -77.23%12.01M | 134.66%52.75M | -8,647.11%-152.19M | 173.93%1.78M | 137.72%650K | -176.15%-1.72M |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | 101.03%152.51K | -857.90%-14.82M | 367.80%1.95M | ---730K | --0 |
| -Less：Restructuring and merger&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.36M | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -181.90%-597.89K | --730K | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | ---- | 101.03%152.51K | ---14.82M | --0 | --0 | ---- |
| Other non- operating income (expenses) | ---- | -100.92%-10K | ---- | ---6K | --1.09M | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 25.88%-8.95M | 30.14%-30M | -2.98M | -12.08M | -323.40%-42.94M | 108.47%19.22M | -320.76%-226.84M | -44.51%-53.91M | 20.54%-37.31M | -39.23%-46.95M |
| Income tax | 0 | 25.91%-532K | -1.14M | 0 | -135.09%-718K | 153.20%2.05M | 53.25%-3.85M | -55.89%-8.23M | 35.27%-5.28M | -52.91%-8.15M |
| Net income | 25.88%-8.95M | 30.21%-29.47M | -1.84M | -12.08M | -345.83%-42.22M | 107.70%17.17M | -388.10%-223M | -42.64%-45.69M | 17.45%-32.03M | -36.66%-38.8M |
| Net income continuous Operations | 25.88%-8.95M | 30.21%-29.47M | ---1.84M | ---12.08M | -345.83%-42.22M | 107.70%17.17M | -388.10%-223M | -42.64%-45.69M | 17.45%-32.03M | -36.66%-38.8M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 25.88%-8.95M | 30.21%-29.47M | -1.84M | -12.08M | -345.83%-42.22M | 107.70%17.17M | -388.10%-223M | -42.64%-45.69M | 17.45%-32.03M | -36.66%-38.8M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 25.88%-8.95M | 30.21%-29.47M | -1.84M | -12.08M | -345.83%-42.22M | 107.70%17.17M | -388.10%-223M | -42.64%-45.69M | 17.45%-32.03M | -36.66%-38.8M |
| Basic earnings per share | 50.00%-0.05 | 42.86%-0.2 | -0.0261 | -0.1 | -359.33%-0.35 | 104.13%0.135 | -27.93%-3.2708 | -13.63%-2.5568 | 19.64%-2.25 | 11.11%-2.8 |
| Diluted earnings per share | 50.00%-0.05 | 42.86%-0.2 | -0.0261 | -0.1 | -3.73%-0.35 | 89.68%-0.3374 | -27.93%-3.2708 | -13.63%-2.5568 | 19.64%-2.25 | 11.11%-2.8 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | GBP | GBP |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg